| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |